Germany’s Stada attracts interest from Fosun Pharma, say sources: Reuters

China’s Shanghai Fosun Pharmaceutical is planning to put in a bid for German generic drugmaker Stada, already at the centre of a takeover battle between two private equity consortia, two people close to the matter said.

Fosun Pharma is also holding early-stage talks with buyout funds including CVC about a potential joint bid, but may decide initially to go it alone, one of the people said.

Fosun Pharma said it currently had no information to disclose.